Swiss Zeptosens Tests the Limits of Detection With Its Planar Waveguide Technology | GenomeWeb

With ultra-sensitive detection down to zeptomoles — just hundreds to thousands of molecules — Zeptosens is confident it can conquer the market for second-wave DNA chips and have an edge in the emerging protein array market. The Witterswil, Switzerland-based startup recently launched its first product, a DNA-chip system co-developed with and marketed by Qiagen.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.